| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1504284
[patent_doc_number] => 06465487
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Inhibition of membrane-associated viral replication'
[patent_app_type] => B1
[patent_app_number] => 09/209033
[patent_app_country] => US
[patent_app_date] => 1998-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10251
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465487.pdf
[firstpage_image] =>[orig_patent_app_number] => 09209033
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/209033 | Inhibition of membrane-associated viral replication | Dec 9, 1998 | Issued |
Array
(
[id] => 1213219
[patent_doc_number] => 06710077
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-23
[patent_title] => 'Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of HIV to uninfected cells and contraceptive compositions comprising the said derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/889250
[patent_app_country] => US
[patent_app_date] => 1998-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5085
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/710/06710077.pdf
[firstpage_image] =>[orig_patent_app_number] => 09889250
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/889250 | Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of HIV to uninfected cells and contraceptive compositions comprising the said derivatives | Dec 7, 1998 | Issued |
Array
(
[id] => 1236145
[patent_doc_number] => 06689814
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-10
[patent_title] => 'Use of dialkyldialkylammonium halide for the preparation of a virucidal medicament intended to be administered by the systemic route'
[patent_app_type] => B1
[patent_app_number] => 09/200977
[patent_app_country] => US
[patent_app_date] => 1998-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2356
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/689/06689814.pdf
[firstpage_image] =>[orig_patent_app_number] => 09200977
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/200977 | Use of dialkyldialkylammonium halide for the preparation of a virucidal medicament intended to be administered by the systemic route | Nov 29, 1998 | Issued |
Array
(
[id] => 4296447
[patent_doc_number] => 06184253
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Remedy for autoimmune diseases'
[patent_app_type] => 1
[patent_app_number] => 9/192990
[patent_app_country] => US
[patent_app_date] => 1998-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3139
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184253.pdf
[firstpage_image] =>[orig_patent_app_number] => 192990
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/192990 | Remedy for autoimmune diseases | Nov 15, 1998 | Issued |
Array
(
[id] => 4294601
[patent_doc_number] => 06180634
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-30
[patent_title] => 'Combination therapy for the treatment of AIDS'
[patent_app_type] => 1
[patent_app_number] => 9/191895
[patent_app_country] => US
[patent_app_date] => 1998-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12056
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/180/06180634.pdf
[firstpage_image] =>[orig_patent_app_number] => 191895
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191895 | Combination therapy for the treatment of AIDS | Nov 12, 1998 | Issued |
Array
(
[id] => 4090379
[patent_doc_number] => 06133309
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/189189
[patent_app_country] => US
[patent_app_date] => 1998-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5730
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133309.pdf
[firstpage_image] =>[orig_patent_app_number] => 189189
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/189189 | Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists | Nov 9, 1998 | Issued |
Array
(
[id] => 4157645
[patent_doc_number] => 06114367
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-05
[patent_title] => 'Isoxazoline compounds as inhibitors of TNF release'
[patent_app_type] => 1
[patent_app_number] => 9/187833
[patent_app_country] => US
[patent_app_date] => 1998-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11414
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 608
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/114/06114367.pdf
[firstpage_image] =>[orig_patent_app_number] => 187833
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/187833 | Isoxazoline compounds as inhibitors of TNF release | Nov 5, 1998 | Issued |
| 09/187784 | USE OF GM-CSF TO INHIBIT DEVELOPMENT OF DRUG RESISTANCE IN HIV+PATIENTS | Nov 5, 1998 | Abandoned |
Array
(
[id] => 4261142
[patent_doc_number] => 06258818
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome'
[patent_app_type] => 1
[patent_app_number] => 9/177942
[patent_app_country] => US
[patent_app_date] => 1998-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10114
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258818.pdf
[firstpage_image] =>[orig_patent_app_number] => 177942
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/177942 | Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome | Oct 22, 1998 | Issued |
Array
(
[id] => 4248888
[patent_doc_number] => 06221853
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Lactulose-based anhydrous composition'
[patent_app_type] => 1
[patent_app_number] => 9/176213
[patent_app_country] => US
[patent_app_date] => 1998-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1270
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221853.pdf
[firstpage_image] =>[orig_patent_app_number] => 176213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/176213 | Lactulose-based anhydrous composition | Oct 20, 1998 | Issued |
Array
(
[id] => 7078209
[patent_doc_number] => 20010041187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'PERFORMANCE-ENHANCING DIETARY SUPPLEMENT'
[patent_app_type] => new
[patent_app_number] => 09/175748
[patent_app_country] => US
[patent_app_date] => 1998-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3646
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041187.pdf
[firstpage_image] =>[orig_patent_app_number] => 09175748
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/175748 | PERFORMANCE-ENHANCING DIETARY SUPPLEMENT | Oct 19, 1998 | Abandoned |
Array
(
[id] => 4183110
[patent_doc_number] => 06020353
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => '2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide'
[patent_app_type] => 1
[patent_app_number] => 9/170697
[patent_app_country] => US
[patent_app_date] => 1998-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3777
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020353.pdf
[firstpage_image] =>[orig_patent_app_number] => 170697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/170697 | 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide | Oct 12, 1998 | Issued |
| 09/162446 | IMPLANTATION RATES AFTER IN VITRO FERTILIZATION, AND TREATMENT OF INFERTILITY AND EARLY PREGNANCY LOSS WITH A NITRIC OXIDE DONOR OR SUBSTRATE ALONE OR IN COMBINATION WITH PROGESTERONE, AND A METHOD FOR CONTRACEPTION WITH NITRIC OXIDE INHIBITORS IN COMBINATION WITH | Sep 28, 1998 | Abandoned |
Array
(
[id] => 1156348
[patent_doc_number] => 06765007
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-20
[patent_title] => 'High-content famciclovir tablets'
[patent_app_type] => B1
[patent_app_number] => 09/101926
[patent_app_country] => US
[patent_app_date] => 1998-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 796
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/765/06765007.pdf
[firstpage_image] =>[orig_patent_app_number] => 09101926
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/101926 | High-content famciclovir tablets | Sep 23, 1998 | Issued |
| 09/153964 | NOVEL COMPOUNDS AND METHODS FOR SYNTHESIS AND THERAPY | Sep 15, 1998 | Abandoned |
Array
(
[id] => 4360368
[patent_doc_number] => 06255312
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Acyclic nucleoside derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/146194
[patent_app_country] => US
[patent_app_date] => 1998-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20246
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255312.pdf
[firstpage_image] =>[orig_patent_app_number] => 146194
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/146194 | Acyclic nucleoside derivatives | Sep 2, 1998 | Issued |
Array
(
[id] => 4296590
[patent_doc_number] => 06197834
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Method of inhibiting formation of infectious herpes virus particles'
[patent_app_type] => 1
[patent_app_number] => 9/145039
[patent_app_country] => US
[patent_app_date] => 1998-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5438
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197834.pdf
[firstpage_image] =>[orig_patent_app_number] => 145039
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/145039 | Method of inhibiting formation of infectious herpes virus particles | Aug 31, 1998 | Issued |
| 09/138397 | THE USE OF LOOP DIURETICS FOR HIV INFECTION | Aug 23, 1998 | Abandoned |
Array
(
[id] => 6876829
[patent_doc_number] => 20010006982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'URINARY INCONTINENCE THERAPY'
[patent_app_type] => new-utility
[patent_app_number] => 09/138448
[patent_app_country] => US
[patent_app_date] => 1998-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4718
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20010006982.pdf
[firstpage_image] =>[orig_patent_app_number] => 09138448
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/138448 | Urinary incontinence therapy | Aug 20, 1998 | Issued |
Array
(
[id] => 4143548
[patent_doc_number] => 06030980
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Agent for the treatment of infections'
[patent_app_type] => 1
[patent_app_number] => 9/135591
[patent_app_country] => US
[patent_app_date] => 1998-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7428
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/030/06030980.pdf
[firstpage_image] =>[orig_patent_app_number] => 135591
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/135591 | Agent for the treatment of infections | Aug 17, 1998 | Issued |